Related Experiment Videos
Clinical trials of idiotype-specific vaccine in B-cell lymphomas
1Division of Oncology, Stanford University School of Medicine, California 94305.
Annals of the New York Academy of Sciences
|August 12, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Work-related stress assessed by a text message single-item stress question.
Occupational medicine (Oxford, England)·2017
Individual and Contextual Socioeconomic Position on Type 2 Diabetes Risk in LMICs: A Multilevel Analysis.
Annals of the New York Academy of Sciences·2026
Critical Review on the Development and Evolution of Beat Perception.
Annals of the New York Academy of Sciences·2026
PIEZO1 Mediates Myoblast Proliferation Under Simulated Microgravity.
Annals of the New York Academy of Sciences·2026
HMM-PMM: A Parallel Hidden Markov Model-Based Map-Matching Framework for Large-Scale Trajectory Data.
Annals of the New York Academy of Sciences·2026
A Residual Spatial Attention Graph Network for Sensorless Force Estimation in Teleoperated Robots.
Annals of the New York Academy of Sciences·2026
Exploring the Sensorimotor System's Role in Emotional Authenticity Discrimination: A ccPAS Study.
Annals of the New York Academy of Sciences·2026
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Interleukin-10 in endometriosis: a systematic review of systemic and local immune compartment differences.
European journal of obstetrics, gynecology, and reproductive biology·2026
CBL0137 inhibits TFR2-mediated IgA1 deposition in IgA nephropathy.
International immunopharmacology·2026